CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15

Jan. 5, 2022 – A CDC advisory panel at this time advisable that 12- to 17-year-olds within the U.S. ought to get the Pfizer COVID-19 booster shot 5 months after a major sequence of vaccinations.

The CDC had already mentioned 16- and 17-year-olds “might” obtain a Pfizer booster however at this time’s suggestion provides the 12-15 group and strengthens the “might” to “ought to” for 16- and 17-year-olds.

The committee voted 13-1 to advocate the booster for ages 12-17.

The vote comes after the FDA on Monday approved the Pfizer vaccine booster dose for 12- to 15-year-olds.

The FDA motion up to date the authorization for the Pfizer vaccine, and the company additionally shortened the advisable time between a second dose and the booster to five months or extra (from 6 months). A 3rd major sequence dose can be now approved for sure immunocompromised youngsters between 5 and 11 years previous. Full particulars can be found in an FDA information launch.

The CDC on Tuesday additionally backed the shortened time-frame and a 3rd major sequence dose for some immunocompromised youngsters 5 to 11 years previous. However the CDC delayed a call on a booster for 12- to 15-year-olds till it heard from its Advisory Committee on Immunization Practices at this time.

The choice got here as college districts nationwide are wrestling with choices of whether or not to maintain colleges open or revert to a digital format as circumstances surge, and as pediatric COVID-19 circumstances and hospitalizations attain new highs.

We will be happy to hear your thoughts

Leave a reply

Enable registration in settings - general
Compare items
  • Total (0)
Shopping cart